Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Nov;5 Suppl 6(Suppl 6):S704-12.
doi: 10.3978/j.issn.2072-1439.2013.10.17.

Minimally invasive surgery for atrial fibrillation

Affiliations
Review

Minimally invasive surgery for atrial fibrillation

Michael O Zembala et al. J Thorac Dis. 2013 Nov.

Abstract

Atrial fibrillation (AF) remains the most common cardiac arrhythmia, affecting nearly 2% of the general population worldwide. Minimally invasive surgical ablation remains one of the most dynamically evolving fields of modern cardiac surgery. While there are more than a dozen issues driving this development, two seem to play the most important role: first, there is lack of evidence supporting percutaneous catheter based approach to treat patients with persistent and long-standing persistent AF. Paucity of this data offers surgical community unparalleled opportunity to challenge guidelines and change indications for surgical intervention. Large, multicenter prospective clinical studies are therefore of utmost importance, as well as honest, clear data reporting. Second, a collaborative methodology started a long-awaited debate on a Heart Team approach to AF, similar to the debate on coronary artery disease and transcatheter valves. Appropriate patient selection and tailored treatment options will most certainly result in better outcomes and patient satisfaction, coupled with appropriate use of always-limited institutional resources. The aim of this review, unlike other reviews of minimally invasive surgical ablation, is to present medical professionals with two distinctly different, approaches. The first one is purely surgical, Standalone surgical isolation of the pulmonary veins using bipolar energy source with concomitant amputation of the left atrial appendage-a method of choice in one of the most important clinical trials on AF-The Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST) Trial. The second one represents the most complex approach to this problem: a multidisciplinary, combined effort of a cardiac surgeon and electrophysiologist. The Convergent Procedure, which includes both endocardial and epicardial unipolar ablation bonds together minimally invasive endoscopic surgery with electroanatomical mapping, to deliver best of the two worlds. One goal remains: to help those in urgent need for everlasting relief.

Keywords: Ablation; Atrial Fibrillation; Minimally invasive surgery.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Modified Left atrial lesion set. The “Dallas” lesion. Courtesy: AtriCure.
Figure 2
Figure 2
Standalone surgical ablation of atrial fibrillation. Clearly visible lesion separating right pulmonary veins from the left atrium. Ablation of ganglionated plexi with unipolar device.
Figure 3
Figure 3
Lesion pattern set of the convergent procedure. Blue lines indicate epicardial, surgical lesions, while red dots–epicardial ablation.
Figure 4
Figure 4
Endoscopic view of the oblique sinus.
Figure 5
Figure 5
Electroanatomical mapping of the left atrium. Status post-surgical ablation. Red indicates non-viable atrial tissue (scar).
Figure 6
Figure 6
Exclusion of the left atrial appendage with a GI stapler.

References

    1. Romero JR, Wolf PA. Epidemiology of Stroke: Legacy of the Framingham Heart Study. Glob Heart 2013;8:67-75 - PMC - PubMed
    1. Jahangir A, Lee V, Friedman PA, et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 2007;115:3050-6 - PubMed
    1. Chugh SS, Blackshear JL, Shen WK, et al. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001;37:371-8 - PubMed
    1. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52 - PubMed
    1. Connolly SJ, Camm AJ, Halperin JL, et al. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011;365:2268-76 - PubMed